Marianne Ewertz

Summary

Affiliation: Odense University Hospital
Country: Denmark

Publications

  1. ncbi Late effects of breast cancer treatment and potentials for rehabilitation
    Marianne Ewertz
    Department of Oncology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Denmark
    Acta Oncol 50:187-93. 2011
  2. ncbi Comorbidity and survival after early breast cancer. A review
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Denmark
    Crit Rev Oncol Hematol 81:196-205. 2012
  3. ncbi Utility of 18FDG-PET/CT in breast cancer diagnostics--a systematic review
    Karina Warning
    Department of Oncology, Odense University Hospital, 5000 Odense, Denmark
    Dan Med Bull 58:A4289. 2011
  4. ncbi PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer
    Jeanette Dupont Jensen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Clin Cancer Res 17:667-77. 2011
  5. ncbi ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
    Jeanette Dupont Jensen
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000 Odense, Denmark
    Breast Cancer Res Treat 132:511-21. 2012
  6. ncbi Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial
    Marianne Ewertz
    Department of Oncology ME, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
    J Clin Oncol 30:3967-75. 2012
  7. ncbi Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000, Odense C, Denmark
    Breast Cancer Res Treat 131:1013-20. 2012

Collaborators

Detail Information

Publications7

  1. ncbi Late effects of breast cancer treatment and potentials for rehabilitation
    Marianne Ewertz
    Department of Oncology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Denmark
    Acta Oncol 50:187-93. 2011
    ..Breast cancer is the most frequent malignant disease among women world wide. Survival has been improving leading to an increasing number of breast cancer survivors, in the US estimated to about 2.6 million...
  2. ncbi Comorbidity and survival after early breast cancer. A review
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Denmark
    Crit Rev Oncol Hematol 81:196-205. 2012
    ..Survival after breast cancer is determined by disease related factors such as stage at diagnosis, patient characteristics, e.g., age, and treatment...
  3. ncbi Utility of 18FDG-PET/CT in breast cancer diagnostics--a systematic review
    Karina Warning
    Department of Oncology, Odense University Hospital, 5000 Odense, Denmark
    Dan Med Bull 58:A4289. 2011
    ..PET/CT should still be regarded as a supplement to conventional diagnostic procedures such as CT and MRI...
  4. ncbi PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer
    Jeanette Dupont Jensen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Clin Cancer Res 17:667-77. 2011
    ..We wished to discern whether selective pressures occur and the influence of PIK3CA mutation on time to recurrence...
  5. ncbi ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
    Jeanette Dupont Jensen
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000 Odense, Denmark
    Breast Cancer Res Treat 132:511-21. 2012
    ..Expression of ER, HER2, and TOP2A displayed discordance with a sufficient frequency to emphasize the role of confirmatory biopsies from metastatic lesions in future management of recurrent breast cancer...
  6. ncbi Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial
    Marianne Ewertz
    Department of Oncology ME, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
    J Clin Oncol 30:3967-75. 2012
    ..7 years of median follow-up...
  7. ncbi Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000, Odense C, Denmark
    Breast Cancer Res Treat 131:1013-20. 2012
    ..While survival improved over time for patients without comorbidity, no improvement was seen among patients with severe comorbidity (CCI 3+)...